Digital Medicine: Clinical Opportunities, Regulatory Changes, and Implementation Barriers
Keywords:
Digital Medicine; telemedicine; artificial intelligence; clinical decision support (CDS); electronic medical records; wearable devices; FDA; cybersecurity; data privacy; digital disparity; low and middle income countries; health care.Abstract
Literature analysis shows that digital medicine can improve clinical decision-making, develop remote medical services, and manage medical data. At the same time, data security, digital inequality, expert training and regulatory issues are preventing its widespread introduction.
References
1.U.S. Food and Drug Administration. FDA Adapts with the Times on Digital Health: Updated Guidances on Clinical Decision Support Software and General Wellness Policy, 6-yanvar 2026.
2.Bipartisan Policy Center. FDA Oversight: Understanding the Regulation of Health AI Tools, 2026.
3.STAT News. FDA announces sweeping changes to oversight of wearables, AI-enabled devices, 6-yanvar 2026.
4.Olayiwola Q.B., Sanusi O.M., Amoo G.S. va boshq. Barriers to digital health implementation in low- and middle-income countries: a narrative review. Discover Public Health, 23(499), 2026.
5.Capodici A., Filippeschi A., Noci F. va boshq. Mapping global inequities in telemedicine implementation: An umbrella review of barriers and facilitators. PLOS One, 2026.
6.Yew S.Q., Trivedi D., Adanan N.I.H., Chew B.H. Facilitators and Barriers to the Implementation of Digital Health Technologies in Hospital Settings in Lower- and Middle-Income Countries Since the Onset of the COVID-19 Pandemic: Scoping Review. JMIR, 2025.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal